Tear

Once-daily consumption of a supplement of lutein, zeaxanthin isomers, curcumin and vitamin D3 improved tear production and reduced ocular surface damage, inflammation and patient-reported symptoms in dry eye disease, according to research.

Okyo Pharma has announced additional findings from its phase 2 trial of OK-101, including statistically significant improvement in ocular pain relief, conjunctival staining and tear breakup time in patients with dry eye disease.

ATLANTA — A long-term study of Vevye for treating dry eye showed an improvement in Schirmer’s scores by 98% at week 46, according to Walter O. Whitley, OD, MBA, FAAO.

CHICAGO — Participants in a pilot study rated comfort and soothing higher with I-Drop MGD compared with their habitual eye drops, according to a poster presented at Optometry’s Meeting.

Patients with severe tear deficiency due to keratoconjunctivitis sicca experienced significant improvements after treatment with OTX-101 0.09% compared with vehicle, according to data published in Current Eye Research.

Patients who underwent a single 5-minute warm compress therapy experienced improved ocular surface characteristics, according to a poster at the virtual Women in Ophthalmology Summer Symposium.

Partial patellar tendon thickness correlates strongly with a partial tendon tear and tracking changes in tendon thickness by MRI may predict the effectiveness of nonoperative treatment in athletes, according to a recently published study.

The Tear Film & Ocular Surface Society announced the availability of an executive summary of the TFOS Dry Eye Workshop II report that is customized for patients.